Search results for: Antibiotics

Taking STRIDES: The value of diagnostics against AMR

10 June 2025

…and projecting public health: Spectrum value: Enables use of narrow-spectrum antibiotics by identifying specific pathogens and resistance patterns. Transmission value: Reduces the spread of infectious and resistant pathogens through earlier…

Pharmacogenomics Testing: A Crucial Piece to Unlocking the Full Value of Medicines

5 June 2025

…prevent ADRs and treatment ineffectiveness, PGx testing can be used to inform prescribing decisions. PGx testing guidelines exist for many commonly prescribed medicines, including blood thinners, antibiotics, and anti-cancer agents….

Vaccines

…illness-related school absenteeism. Furthermore, vaccines aid in reducing the overuse of antibiotics, tackling the challenge of antimicrobial resistance. In essence, vaccines constitute a cornerstone of public health, not only safeguarding…

The changing role of the NHS over time

14 August 2023

…development of vaccines, antibiotics, and improved living conditions greatly reduced the morbidity and mortality associated with many of these diseases (Office of Health Economics, 1974). As the life expectancy of…

Medicine

…antibiotics, health economists contribute to the development of novel payment models. They address barriers to innovation by designing payment structures that incentivize antibiotic development despite challenges in market attractiveness.  Resource…

OHE’s submission for the DHSC’s next 10 years of planning

9 December 2024

…implications. The UK is a world leader in novel incentive models of payment – NICE and NHS England’s pioneering trial of the ‘subscription’ model for antibiotics, has the potential to…

Cystic Fibrosis

1 March 1986

…25 years. The reasons for this improvement reflect a consortium of factors: earlier diagnosis, the availability and appropriate use of effective antibiotics and improved patterns of health care. They have…

Antibacterials: Roundtable Addresses the Critical Issues

10 November 2011

…raised included the danger of stewardship being a screen for anticompetitive behavior, the need to include generics, and the possibility of a tax on newly-generic antibiotics to raise funds for…

Spotlight on OHE: Adaptive Pathways, Economic Evaluation, Stated Preferences and Life-cycle Price Modelling

5 November 2014

…to look closely at models of health economic evaluation in France, Germany and the UK. This presentation can be watched here http://www.youtube.com/watch?v=AyoScR9BjuU, from 00:29:27 to 1:28:00.   Antibiotics and the…